Joshua L. Lachowicz

An orally bioavailable parthenolide analog selectively eradicates acute myelogenous leukemia stem and progenitor cells

Mónica L. Guzmán, Randall M. Rossi, Sundar Neelakantan et al. · Blood · 2007 · 410 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +14

Intratumoral injection of <i>Clostridium novyi</i> -NT spores induces antitumor responses

Nicholas J. Roberts, Linping Zhang, Filip Jankú et al. · Science Translational Medicine · 2014 · 395 citations · Full text

Medicine, Microbiology, Oncology +13

Asparaginase and MOPP Treatment of Dogs with Lymphoma

E. M. Brodsky, G.N. Maudlin, Joshua L. Lachowicz et al. · Journal of Veterinary Internal Medicine · 2009 · 72 citations · Full text

Medicine, Oncology, Pharmacology +14

Mutations in the fifth immunoglobulin‐like domain of kit are common and potentially sensitive to imatinib mesylate in feline mast cell tumours

Mayu Isotani, Osamu Yamada, Joshua L. Lachowicz et al. · British Journal of Haematology · 2009 · 63 citations · Full text

Medicine, Immunology, Oncology +15

Phase II study of the oral selective inhibitor of nuclear export (SINE) KPT-335 (verdinexor) in dogs with lymphoma

Abbey R. Sadowski, Heather L. Gardner, Antonella Borgatti et al. · BMC Veterinary Research · 2018 · 45 citations · Full text

Medicine, Oncology, Pharmacology +14